secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001161697-25-000371
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical Q3 revenue $10.4M (+27% YoY), raises full-year guidance
--------------------------------------------------------------------

- Q3 net revenues $10.4M, up 27% YoY; core business (domestic + international) $9.8M, up 30%.
- Net loss narrowed 51% to $0.8M; positive adjusted EBITDA of $0.09M vs. $(0.4M) prior year.
- International core revenue surged 229.6% to $3.7M; domestic core declined 5.0%.
- Raising FY2025 revenue guidance to $40.5-41.0M (from $39.5-40.5M); gross margin guidance reiterated at 61-63%.
- Ending cash balance $8.5M; generated $0.4M cash in Q3; reiterating positive full-year cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169725000371/0001161697-25-000371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169725000371/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-25-000371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer